Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
03/2012
03/01/2012WO2012003205A3 Vaccine against ehrlichia canis
03/01/2012WO2011158122A3 Anti-human equilibrative nucleoside transporter 1 (hent1) antibodies and methods of use thereof
03/01/2012WO2011156617A3 Anti-egfr antibodies
03/01/2012WO2011155998A3 Oral vaccination of fish with live attenuated edwardsiella ictaluri vaccines
03/01/2012WO2011151760A3 Streptococcus pneumoniae vaccine formulations
03/01/2012WO2011143562A3 Il-1 binding proteins
03/01/2012WO2011139986A3 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of arginyl-trna synthetases
03/01/2012WO2011139973A3 Methods of inhibiting fibrosis using anti-pai-1 antibodies
03/01/2012WO2011137540A8 Gfi1b modulation and uses thereof
03/01/2012WO2011133897A3 Methods and materials for reducing liver fibrosis
03/01/2012WO2011130301A9 Method of diagnosing and treating melioidosis
03/01/2012WO2011121560A3 Stabilized antibody preparations and uses thereof
03/01/2012WO2011119628A3 Compositions and methods for self-adjuvanting vaccines against microbes and tumors
03/01/2012WO2011106100A3 Method of inducing the production of protective anti-hiv-1 antibodies
03/01/2012US20120054879 HCV Coreceptor and Methods of Use Thereof
03/01/2012US20120053509 Vaccines for human papilloma virus and methods for using the same
03/01/2012US20120052116 Immunogenic epitopes of ngep antigen
03/01/2012US20120052110 Methods and compositions for promoting wound healing
03/01/2012US20120052093 Compositions and methods for preventing and treating uterine disease
03/01/2012US20120052092 Vaccine compositions comprising a mutated factor h binding protein
03/01/2012US20120052091 Potomac horse fever isolates
03/01/2012US20120052090 Peptidic antigen that induces antibody recognizing three-dimensional structure of hiv and method for synthesizing same
03/01/2012US20120052089 Newcastle disease virus vectored herpesvirus vaccines
03/01/2012US20120052088 Pneumococcal vaccine and uses thereof
03/01/2012US20120052087 Siderophore Conjugate Immunogenic Compositions and Vaccines
03/01/2012US20120052086 Vaccine composition for prophylaxis and/or therapy of alzheimer's disease
03/01/2012US20120052085 Vaccines against tularemia
03/01/2012US20120052084 Staphylococcus aureus proteins and nucleic acids
03/01/2012US20120052083 MUTANT CyaA POLYPEPTIDES AND POLYPEPTIDE DERIVATIVES SUITABLE FOR THE DELIVERY OF IMMUNOGENIC MOLECULES INTO A CELL
03/01/2012US20120052082 Cross-protective influenza vaccine
03/01/2012US20120052081 Compositions for use in the treatment of chronic obstructive pulmonary diseases and asthma
03/01/2012US20120052080 Interleukin-13 receptor alpha 2 peptide-based brain cancer vaccines
03/01/2012US20120052079 Compositions, Kits, and Methods for Predicting Anti-Cancer Response to Anthracyclines
03/01/2012US20120052078 Generation and profiling of fully human hucal gold-derived therapeutic antibodies specific for human cd38
03/01/2012US20120052077 Therapeutic modulation of vaginal epithelium boundary lubrication
03/01/2012US20120052076 Anti-trop-2 monoclonal antibodies and uses thereof in the treatment and diagnosis of tumors
03/01/2012US20120052075 Modulation of the vps10p-domain receptor family for the treatment of mental and behavioural disorders
03/01/2012US20120052074 Human monoclonal antibodies to activin receptor-like kinase-1
03/01/2012US20120052073 Antibodies Directed to Angiopoietin-2 And Uses Thereof
03/01/2012US20120052072 High affinity human antibodies to human il-4 receptor
03/01/2012US20120052071 Tumor markers and methods of use thereof
03/01/2012US20120052070 Compositions and methods of use for binding molecules to dickkopf-1 or dickkopf-4 or both
03/01/2012US20120052069 Fgf21 mutants and uses thereof
03/01/2012US20120052068 Autophilic antibodies and method of making the same
03/01/2012US20120052067 Activin-actrii antagonists and uses for increasing red blood cell levels
03/01/2012US20120052066 Markers and methods for assessing and treating lupus patients susceptible to photoprovocation
03/01/2012US20120052065 Methods of treatment using ctla4 mutant molecules
03/01/2012US20120052064 Anti-hgf antibody combinational cancer therapies
03/01/2012US20120052063 Automated detection of breast cancer lesions in tissue
03/01/2012US20120052062 Methods for Treatment of Non-Small Cell Lung Cancer
03/01/2012US20120052061 Therapies for treating cancer using combinations of cox-2 inhibitors and anti-her2(erbb2) antibodies or combinations of cox-2 inhibitors and her2(erbb2) receptor tyrosine kinase inhibitors
03/01/2012US20120052060 Human Antibody Molecules For IL-13
03/01/2012US20120052059 Regulatory b cells and their use
03/01/2012US20120052058 Methods of managing the blood coagulation and pharmaceutical compositions related thereto
03/01/2012US20120052057 method for selecting responders to blockade of integrin receptors
03/01/2012US20120052055 Method of treating thrombocytopenia
03/01/2012US20120052045 Compositions and methods for modulating ischemic injury
03/01/2012US20120052044 Uses of mammalian cytokine; related reagents
03/01/2012US20120052042 Amphiphilic compounds and self-assembling compositions made therefrom
03/01/2012US20120052007 Peripheral blood sparc binding antibodies and uses thereof
03/01/2012CA2811993A1 Animal model for the evaluation of the efficacy of an hiv vaccine
03/01/2012CA2809433A1 Dual variable domain immunoglobulins and uses thereof
03/01/2012CA2809369A1 Notum protein modulators and methods of use
03/01/2012CA2809362A1 Interleukin-13 receptor alpha 2 peptide-based brain cancer vaccines
03/01/2012CA2809230A1 Immunogenic composition
03/01/2012CA2809089A1 Anti-ox40 antibodies and methods of using the same
03/01/2012CA2809029A1 Targeted multi-epitope dosage forms for induction of an immune response to antigens
03/01/2012CA2808975A1 Stable formulations of neisseria meningitidis rlp2086 antigens
03/01/2012CA2808539A1 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of tyrosyl-trna synthetases
03/01/2012CA2808418A1 Antibodies to matrix metalloproteinase 9
03/01/2012CA2808282A1 Improved enteric active substance delivery
03/01/2012CA2805054A1 Antibodies against il-18r1 and uses thereof
03/01/2012CA2802721A1 Novel agonists of toll-like receptor 3 and methods of their use
02/2012
02/29/2012EP2423335A2 Chimeric immunomodulatory compounds and methods of using the same
02/29/2012EP2423314A1 Vector systems
02/29/2012EP2423311A1 Method for preparing cell pharmaceutical
02/29/2012EP2423231A2 PRLR-specific antibody and uses thereof
02/29/2012EP2423230A1 Binding member for GM-CSF receptor
02/29/2012EP2423229A1 Binding member for GM-CSF receptor
02/29/2012EP2423228A1 Antibody containing igg2 having amino acid mutation introduced therein
02/29/2012EP2423227A1 Human antibodies to human delta like ligand 4
02/29/2012EP2423226A2 Antibody-based diagnostics and therapeutics
02/29/2012EP2422812A1 Methods for preventing and treating tissue damage associated with ischemia-reperfusion injury
02/29/2012EP2422811A2 Modulation of antibody specificity by tailoring the affinity to cognate antigens
02/29/2012EP2422810A1 Influenza vaccine
02/29/2012EP2422809A1 Novel vaccine formulations
02/29/2012EP2422804A1 Controlled release formulations of enzymes, microorganisms, and antibodies with mucoadhesive polymers
02/29/2012EP2421952A2 Compositions for transfection of biomolecules into cells
02/29/2012EP2421899A1 Anti-human ror1 antibodies
02/29/2012EP2421892A1 Control of protein glycosylation and compositions and methods relating thereto
02/29/2012EP2421891A1 Immunogenic epitopes of ngep antigen
02/29/2012EP2421888A1 A novel cell and therapeutical and diagnostical methods based thereon
02/29/2012EP2421611A1 Fgfr1c antibody combinations
02/29/2012EP2421563A1 Innate immune suppression enables repeated delivery of long rna molecules
02/29/2012EP2421559A2 Anti-tgf-beta induction of bone cell function and bone growth
02/29/2012EP2421558A1 Adjuvant cancer therapy
02/29/2012EP2421557A1 A tuberculosis tb vaccine to prevent reactivation
02/29/2012EP2421556A1 Vaccines comprising attenuated mycoplasma bovis strains and method for the attenuation
02/29/2012EP2421555A2 Nucleic acid molecule
02/29/2012EP2421546A1 Replikin-sequences for preventing/treating influenza and determining infectivity/lethality
1 ... 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 ... 1823